STREAM: why 'noninferior' does not make stopping statins at age 70 safe
Louis shares a cardiologist's video commentary on the STREAM randomized trial of stopping statins after age 70. The commentary stresses that the stop group had roughly 38% more events in relative terms (12.7% vs 9.2%), that noninferiority only means the difference fell within a preset margin, and that the safety board advised discussing restarting. Stopping can be appropriate based on frailty or side effects, but not simply because of age.
